Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Akoya Biosciences Inc (AKYA)

Akoya Biosciences Inc (AKYA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 441,683
  • Shares Outstanding, K 37,590
  • Annual Sales, $ 54,920 K
  • Annual Income, $ -42,940 K
  • 60-Month Beta 0.93
  • Price/Sales 7.33
  • Price/Cash Flow N/A
  • Price/Book 4.70
Trade AKYA with:

Options Overview Details

View History
  • Implied Volatility 60.61% ( -7.09%)
  • Historical Volatility 79.19%
  • IV Percentile 6%
  • IV Rank 22.87%
  • IV High 192.06% on 05/09/22
  • IV Low 21.64% on 09/23/22
  • Put/Call Vol Ratio 3.00
  • Today's Volume 4
  • Volume Avg (30-Day) 10
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 605
  • Open Int (30-Day) 738

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.37
  • Number of Estimates 3
  • High Estimate -0.30
  • Low Estimate -0.44
  • Prior Year -0.31
  • Growth Rate Est. (year over year) -19.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.51 +11.80%
on 09/30/22
13.81 -14.89%
on 09/09/22
+0.54 (+4.82%)
since 08/30/22
3-Month
10.51 +11.80%
on 09/30/22
16.57 -29.09%
on 08/09/22
-1.10 (-8.56%)
since 06/30/22
52-Week
8.02 +46.51%
on 05/10/22
16.57 -29.09%
on 08/09/22
-2.21 (-15.83%)
since 09/30/21

Most Recent Stories

More News
Akoya Biosciences, Inc. (AKYA) Q2 2022 Earnings Call Transcript

AKYA earnings call for the period ending June 30, 2022.

AKYA : 11.75 (+9.71%)
Akoya Biosciences (AKYA) Reports Q2 Loss, Tops Revenue Estimates

Akoya (AKYA) delivered earnings and revenue surprises of -38.24% and 5.69%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

AKYA : 11.75 (+9.71%)
MXCT : 6.50 (+3.50%)
Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates

Adaptive Biotechnologies (ADPT) delivered earnings and revenue surprises of 7.50% and 0.82%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

ADPT : 7.12 (+3.94%)
AKYA : 11.75 (+9.71%)
Akoya to Participate at Two Upcoming Investor Conferences

MARLBOROUGH, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced...

AKYA : 11.75 (+9.71%)
Akoya to Report Second Quarter 2022 Financial Results on August 8th, 2022

MARLBOROUGH, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced...

AKYA : 11.75 (+9.71%)
Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s Proprietary OncoSignature® Test into a Companion Diagnostic

The OncoSignature® test developed based on Acrivon’s AP3 platform is a first-of-its-kind spatial signature assay to identify patients most likely to...

AKYA : 11.75 (+9.71%)
Acadia (ACAD) Surges 15.5%: Is This an Indication of Further Gains?

Acadia (ACAD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the...

ACAD : 16.36 (+1.36%)
AKYA : 11.75 (+9.71%)
Akoya Biosciences to Highlight Novel Spatial Transcriptomics Capabilities on PhenoCycler-Fusion at AGBT 2022 Annual Meeting

PhenoCycler™-Fusion will enable single-cell, whole-slide spatial multiomic capabilities on a single platform...

AKYA : 11.75 (+9.71%)
Akoya Biosciences, Inc. (AKYA) Q1 2022 Earnings Call Transcript

AKYA earnings call for the period ending March 31, 2022.

AKYA : 11.75 (+9.71%)
Akoya Biosciences (AKYA) Reports Q1 Loss, Tops Revenue Estimates

Akoya (AKYA) delivered earnings and revenue surprises of -18.92% and 14.23%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

AKYA : 11.75 (+9.71%)
IDYA : 14.92 (+5.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Akoya Biosciences Inc. offers comprehensive single-cell imaging solutions which allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. The company offer distinct solutions, the CODEX(R) and Phenoptics(TM)...

See More

Key Turning Points

3rd Resistance Point 14.39
2nd Resistance Point 13.36
1st Resistance Point 12.56
Last Price 11.75
1st Support Level 10.73
2nd Support Level 9.70
3rd Support Level 8.90

See More

52-Week High 16.57
Fibonacci 61.8% 13.30
Fibonacci 50% 12.30
Last Price 11.75
Fibonacci 38.2% 11.29
52-Week Low 8.02

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar